Revance Therapeutics (RVNC) - Market capitalization

Last known market cap: NZ$0.63 Billion

On April 9, 2025 Revance Therapeutics had a market cap of NZ$0.63 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2025

End of year Market Cap

Year	Marketcap	Change
2025	NZ$0.65 B	16.15%
2024	NZ$0.56 B	-53.59%
2023	NZ$1.22 B	-48.98%
2022	NZ$2.39 B	39.45%
2021	NZ$1.71 B	-34.37%
2020	NZ$2.61 B	107.09%
2019	NZ$1.26 B	13.75%
2018	NZ$1.10 B	-39.38%
2017	NZ$1.83 B	114.79%
2016	NZ$0.85 B	-39.65%
2015	NZ$1.41 B	174.68%
2014	NZ$0.51 B

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Johnson & Johnson JNJ	NZ$983.10 B	153,719.22%	🇺🇸 USA
Biogen BIIB	NZ$47.15 B	7,277.92%	🇺🇸 USA
MediciNova MNOV	NZ$0.12 B	-80.52%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Revance Therapeutics (RVNC)

Last known market cap: NZ$0.63 Billion